← Back to headlines
Protara Therapeutics Stock Gains as JP Morgan Initiates Overweight Rating
Protara Therapeutics saw its stock rise after JP Morgan initiated coverage of the company with an 'overweight' rating.
4 Mar, 15:07 — 4 Mar, 15:07
Sources
Showing 1 of 1 sources
Related Stories
Mark Cuban Joins Debate on Proposed California Wealth Tax
1h ago
SEC Proposal Would Allow Companies to Announce Earnings Quarterly, Ditch Filings
2h ago
UK Job Security Weakens to Lowest Since 2023 Amid Dips in Consumer Confidence
2h ago
Market Rises on Strong Earnings, But Wall Street Price Targets Remain Unchanged
3h ago